Patent Assignment
Reel/Frame 056644/0468
Assignment of Assignor's Interest
Recorded: 2021-06-23
Pages: 3
Assignor
NAKAMURA, EIJIRO
Executed: 2021-03-22
Assignee
SUMITOMO DAINIPPON PHARMA CO., LTD.
608, DOSHO-MACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 5418524, JAPAN
Covered Property
(1)
Cancer Treatment Pharmaceutical Composition Containing Cdk Inhibitor
Application:
17/417,727 →
Publication:
US 2022/0071978
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the Address of the Assignee Previously Recorded on Reel 056644 Frame 0468. Assignor(S) Hereby Confirms the Assignment.
Jul 1, 2021
From: NAKAMURA, EIJIRO
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 056751/0009 →
Change of Name
May 20, 2022
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 059972/0983 →